Sign inJoin waitlistJoin the waitlist

JH

Jayme Heim

Physician Assistant · Jack A Dekkinga MD PC

Credentials: · ·

History

Jack A Dekkinga MD PC
Present

Research

Quality of life and patient-reported symptoms in a Phase 4, real-world study of tildrakizumab in patients with moderate-to-severe psoriasis: Week 28 interim analysis
Journal of Dermatological Treatment · 2023 · 12 citations
Long-term quality of life outcomes from a phase 4 study of tildrakizumab in patients with moderate-to-severe plaque psoriasis in a real-world setting
Journal of Dermatological Treatment · 2024 · 11 citations
Tildrakizumab Real-World Effectiveness and Safety Over 64 Weeks in Patients With Moderate-to-Severe Plaque Psoriasis
Journal of Drugs in Dermatology · 2024 · First of 8 authors · 10 citations

JV
Juan Vasquez
6 papers
NB
Neal Bhatia
6 papers
John Koo
4 papers
TB
Tina Bhutani-Jacques
4 papers
TF
Thomas Ferro
3 papers